198 related articles for article (PubMed ID: 1158085)
21. The effect of increased hepatic sitosterol on the regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase and cholesterol 7 alpha-hydroxylase in the rat and sitosterolemic homozygotes.
Shefer S; Salen G; Bullock J; Nguyen LB; Ness GC; Vhao Z; Belamarich PF; Chowdhary I; Lerner S; Batta AK
Hepatology; 1994 Jul; 20(1 Pt 1):213-9. PubMed ID: 8020891
[TBL] [Abstract][Full Text] [Related]
22. Increase of deoxycholate in supersaturated bile of patients with cholesterol gallstone disease and its correlation with de novo syntheses of cholesterol and bile acids in liver, gallbladder emptying, and small intestinal transit.
Shoda J; He BF; Tanaka N; Matsuzaki Y; Osuga T; Yamamori S; Miyazaki H; Sjövall J
Hepatology; 1995 May; 21(5):1291-302. PubMed ID: 7737634
[TBL] [Abstract][Full Text] [Related]
23. Pectin feeding influences fecal bile acid excretion, hepatic bile acid and cholesterol synthesis and serum cholesterol in rats.
Garcia-Diez F; Garcia-Mediavilla V; Bayon JE; Gonzalez-Gallego J
J Nutr; 1996 Jul; 126(7):1766-71. PubMed ID: 8683337
[TBL] [Abstract][Full Text] [Related]
24. Influence of bezafibrate on hepatic cholesterol metabolism in gallstone patients: reduced activity of cholesterol 7 alpha-hydroxylase.
Ståhlberg D; Reihnér E; Rudling M; Berglund L; Einarsson K; Angelin B
Hepatology; 1995 Apr; 21(4):1025-30. PubMed ID: 7705775
[TBL] [Abstract][Full Text] [Related]
25. Circulating markers for biosynthesis of cholesterol and bile acids are not depressed in asymptomatic gallstone subjects.
Muhrbeck O; Wang FH; Björkhem I; Axelson M; Einarsson K
J Hepatol; 1997 Jul; 27(1):150-5. PubMed ID: 9252089
[TBL] [Abstract][Full Text] [Related]
26. Role of newly synthesized cholesterol or its metabolites on the regulation of bile acid biosynthesis after short-term biliary diversion in the rat.
Vlahcevic ZR; Pandak WM; Hylemon PB; Heuman DM
Hepatology; 1993 Sep; 18(3):660-8. PubMed ID: 8359807
[TBL] [Abstract][Full Text] [Related]
27. Cholesterol and bile acid metabolism after selective portal vein ligation.
Makino I; Chijiiwa K; Fukushima K; Kameoka N; Komura M; Kuroki S; Yamashita H; Tanaka M
J Surg Res; 1997 Mar; 68(2):91-8. PubMed ID: 9184666
[TBL] [Abstract][Full Text] [Related]
28. Oleic acid-induced cholelithiasis in the rabbit: conversion of dietary oleic acid to cholestanol as a cause of calcium-bile salt gallstones.
Lee SP; Tasman-Jones C; Carlisle VF
Hepatology; 1987; 7(3):529-34. PubMed ID: 3570164
[TBL] [Abstract][Full Text] [Related]
29. Effects of short-term treatment with pravastatin on the hepatic synthesis of cholesterol and bile acids in gallstone patients.
Hillebrant CG; Axelson M; Björkhem I; Wang FH; Nyberg B; Einarsson C
Eur J Clin Invest; 1998 Apr; 28(4):324-8. PubMed ID: 9615912
[TBL] [Abstract][Full Text] [Related]
30. Cholesterol gallstone formation and prevention by chenodeoxycholic and ursodeoxycholic acids. A new hamster model.
Pearlman BJ; Bonorris GG; Phillips MJ; Chung A; Vimadalal S; Marks JW; Schoenfield LJ
Gastroenterology; 1979 Oct; 77(4 Pt 1):634-41. PubMed ID: 467920
[TBL] [Abstract][Full Text] [Related]
31. Increased activity of hepatic microsomal triglyceride transfer protein and bile acid synthesis in gallstone disease.
Castro J; Amigo L; Miquel JF; Gälman C; Crovari F; Raddatz A; Zanlungo S; Jalil R; Rudling M; Nervi F
Hepatology; 2007 May; 45(5):1261-6. PubMed ID: 17464999
[TBL] [Abstract][Full Text] [Related]
32. Gallstone prevention in prairie dogs: comparison of chow vs. semisynthetic diets.
Cohen BI; Mosbach EH; McSherry CK; Stenger RJ; Kuroki S; Rzigalinski B
Hepatology; 1986; 6(5):874-80. PubMed ID: 3758942
[TBL] [Abstract][Full Text] [Related]
33. Ursodeoxycholic acid treatment in cholesterol gallstone disease: effects on hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity, biliary lipid composition, and plasma lipid levels.
Angelin B; Ewerth S; Einarsson K
J Lipid Res; 1983 Apr; 24(4):461-8. PubMed ID: 6854153
[TBL] [Abstract][Full Text] [Related]
34. Relationship between hepatic cholesterol synthesis and biliary cholesterol secretion in man: hepatic cholesterol synthesis is not a major regulator of biliary lipid secretion.
Maton PN; Reuben A; Dowling RH
Clin Sci (Lond); 1982 May; 62(5):515-9. PubMed ID: 7075149
[TBL] [Abstract][Full Text] [Related]
35. Hepatic cholesterol metabolism in patients with cholesterol gallstones: enhanced intracellular transport of cholesterol.
Ito T; Kawata S; Imai Y; Kakimoto H; Trzaskos JM; Matsuzawa Y
Gastroenterology; 1996 May; 110(5):1619-27. PubMed ID: 8613070
[TBL] [Abstract][Full Text] [Related]
36. Gallstone formation in cholestanol-fed mice.
Kim KS; Kano K; Hirabayashi N; Shefer S; Salen G; Seyama Y
J Biochem; 1993 Apr; 113(4):420-4. PubMed ID: 8514731
[TBL] [Abstract][Full Text] [Related]
37. Increased bile acid concentration in liver tissue with cholesterol gallstone disease.
Honda A; Yoshida T; Tanaka N; Matsuzaki Y; He B; Shoda J; Osuga T
J Gastroenterol; 1995 Feb; 30(1):61-6. PubMed ID: 7719416
[TBL] [Abstract][Full Text] [Related]
38. Mechanism of estrogen-induced saturated bile in the hamster.
Bonorris GG; Coyne MJ; Chung A; Schoenfield LJ
J Lab Clin Med; 1977 Dec; 90(6):963-70. PubMed ID: 925485
[No Abstract] [Full Text] [Related]
39. Prevention of cholesterol-induced gallstones by hyodeoxycholic acid in the prairie dog.
Singhal AK; Cohen BI; Mosbach EH; Une M; Stenger RJ; McSherry CK; May-Donath P; Palaia T
J Lipid Res; 1984 Jun; 25(6):539-49. PubMed ID: 6747458
[TBL] [Abstract][Full Text] [Related]
40. Hamsters predisposed to sucrose-induced cholesterol gallstones (LPN strain) are more resistant to excess dietary cholesterol than hamsters that are not sensitive to cholelithiasis induction.
Souidi M; Combettes-Souverain M; Milliat F; Eckhardt ER; Audas O; Dubrac S; Parquet M; Férézou J; Lutton C
J Nutr; 2001 Jun; 131(6):1803-11. PubMed ID: 11385071
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
